Skip to content Skip to navigation menu

HEK Media

Our high performing HEK media are designed to best fit with the high variability of HEK293 cell lines, the versatility of AAV and complexity of viral vector processes from early clinical phases to large commercial scale.

​Human embryonic kidney (HEK 293) cells and human cell lines are commonly used for Gene Therapy applications (AdenoAssociated Virus) , Gene Modified Cell therapy (Lentivirus), Viral vector Vaccines( Adenovirus) and Proteins production.


Choose your product

Products (5)

Suitable for HEK (e.g., HEK293) and other human cell lines for Infection & Stable expression in suspension

Chemically defined, serum-free, animal component-free, serum-free and hydrolysate-free

Little or no adaptation required from other serum-free media

Supports stable growth of suspension cells at high viability in seed train culture

Manufactured under ISO 9001 QMS (Quality Statement)


HEK media and feed portfolio
en 638.9 kB

User Manual

Protocol for use - HEK TF
en 265.9 kB
Protocol for use - HEK ViP NB
en 230.8 kB
Protocol for use - HEK ViP NX
en 231.9 kB
Protocol for use - HEK FS
en 218.2 kB
Protocol for use - HEK GM
en 210.7 kB

Free HEK293 Media Sample Kit

Sample media for gene therapy and viral vector vaccines

Request Your Sample

Featured Assets

Application Note

Adaptation of Mammalian Cell Lines to Serum-Free Suspension Culture

PDF 315.3 KB
Application Note

The Tested Protocol to Scale Up AAV Production With HEK293 Host Cells

Efficient AAV production starts with scalable upstream manufacturing. Learn how to scale up AAV production using HEK293 host cells.

Download Application Note